Legato Capital Management LLC Purchases New Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Legato Capital Management LLC bought a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 8,110 shares of the company's stock, valued at approximately $778,000.

Several other institutional investors and hedge funds also recently made changes to their positions in HQY. Holocene Advisors LP acquired a new position in HealthEquity in the 3rd quarter valued at $1,246,000. GSA Capital Partners LLP bought a new position in HealthEquity during the third quarter worth about $638,000. Natixis Advisors LLC raised its stake in HealthEquity by 29.8% in the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company's stock worth $17,122,000 after purchasing an additional 48,009 shares in the last quarter. Vaughan Nelson Investment Management L.P. boosted its holdings in HealthEquity by 36.7% in the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock valued at $69,034,000 after purchasing an additional 226,563 shares during the period. Finally, Loomis Sayles & Co. L P grew its position in shares of HealthEquity by 2.2% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company's stock worth $92,216,000 after purchasing an additional 24,665 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Price Performance

Shares of HealthEquity stock traded down $1.25 during midday trading on Monday, hitting $112.69. 483,217 shares of the company traded hands, compared to its average volume of 763,365. The firm's fifty day moving average price is $102.38 and its 200-day moving average price is $91.18. The stock has a market cap of $9.77 billion, a price-to-earnings ratio of 103.39, a PEG ratio of 1.61 and a beta of 0.55. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the firm posted $0.40 earnings per share. As a group, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analyst Weigh In

HQY has been the subject of a number of analyst reports. Barrington Research lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Monday, December 2nd. Mizuho started coverage on HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price objective for the company. Bank of America upped their target price on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a research report on Wednesday, November 13th. Royal Bank of Canada raised their price target on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research report on Tuesday, December 10th. Finally, BTIG Research upped their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, HealthEquity currently has an average rating of "Moderate Buy" and a consensus target price of $110.71.

Insider Activity at HealthEquity

In other news, Director Stuart B. Parker sold 25,000 shares of the firm's stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,000 shares of company stock worth $3,895,788 over the last quarter. Company insiders own 2.20% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.